Search
for
Sort by
Research 31–60 of 1000+
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Biological observations from feeding heated corn oil and heated peanut oil to rats
- Mediterranean Basin Erica Species: Traditional Uses, Phytochemistry and Pharmacological Properties
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- 138 Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles
- VP-16-213 (etoposide): The mandrake root from Issyk-Kul
- Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases
- From Weed to Wonder: Exploring the Multifaceted Pharmacological Actions of Tridax procumbens Linn.
- Eflornithine Hydrochloride-Loaded Electrospun Nanofibers as a Potential Face Mask for Hirsutism Application
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia
- Experience with sonidegib in patients with advanced basal cell carcinoma: case reports
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Docetaxel.
- Scientific Basis for the Therapeutic Uses of Semecarpus anacardium Linn. (Bhallataka): A Systematic Review
- ASSESSMENT OF SOCIODEMOGRAPHIC CHARACTERISTICS AND COMPARATIVE ANALYSIS OF ADVERSE DRUG REACTIONS AMONG OROPHARYNGEAL CANCER PATIENTS RECEIVING DIFFERENT CHEMOTHERAPEUTIC REGIMENS IN KARACHI, SINDH, PAKISTAN
- Development of PEGylated Liposomes
- Getting under the skin: what is the potential of the transfollicular route in drug delivery?
- The anti-inflammatory and analgesic activities of 2Br-Crebanine and Stephanine from Stephania yunnanenses H. S.Lo
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Nanostructured Lipid Carrier for Hyperpigmentation Treatment - a Dermal Prospective
- A review on phytochemical, ethnomedical and pharmacological studies on genus Sophora, Fabaceae